These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 32931001)
21. Current opinion on the regulation of small intestinal magnesium absorption. Chamniansawat S; Suksridechacin N; Thongon N World J Gastroenterol; 2023 Jan; 29(2):332-342. PubMed ID: 36687126 [TBL] [Abstract][Full Text] [Related]
22. [Hypomagnesemia and hypocalcemia associated with chronic omeprazole use]. Cuesta Miyares J; López Caleya JF; Martín Rodrigo L Semergen; 2020; 46(1):e1-e2. PubMed ID: 31785990 [No Abstract] [Full Text] [Related]
23. Suppression of contractile activity in the small intestine by indomethacin and omeprazole. Lichtenberger LM; Bhattarai D; Phan TM; Dial EJ; Uray K Am J Physiol Gastrointest Liver Physiol; 2015 May; 308(9):G785-93. PubMed ID: 25721304 [TBL] [Abstract][Full Text] [Related]
24. Omeprazole increased small intestinal mucosal injury in two of six disease-free cases evaluated by capsule endoscopy. Fujimori S; Takahashi Y; Tatsuguchi A; Sakamoto C Dig Endosc; 2014 Sep; 26(5):676-9. PubMed ID: 25383403 [TBL] [Abstract][Full Text] [Related]
25. Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats. Kim KB; Chang MS; Chung YK; Sohn SK; Kim SG; Choi WS J Pharm Pharmacol; 1998 May; 50(5):521-9. PubMed ID: 9643446 [TBL] [Abstract][Full Text] [Related]
27. Isolated hypomagnesemia in a patient treated with capecitabine. Rajapakse S; Rodrigo C; Rajapakse AC J Oncol Pharm Pract; 2013 Sep; 19(3):254-6. PubMed ID: 22948887 [TBL] [Abstract][Full Text] [Related]
28. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo. Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936 [TBL] [Abstract][Full Text] [Related]
29. Consistent gastric pH-dependent effects of suppressors of gastric acid secretion on the antihypertensive responses to oral nitrite. Sanches-Lopes JM; Ferreira GC; Pinheiro LC; Kemp R; Tanus-Santos JE Biochem Pharmacol; 2020 Jul; 177():113940. PubMed ID: 32224135 [TBL] [Abstract][Full Text] [Related]
30. Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and Ulcers. Goldstein JL; Scheiman JM; Fort JG; Whellan DJ J Cardiovasc Pharmacol; 2016 Aug; 68(2):121-6. PubMed ID: 27002280 [TBL] [Abstract][Full Text] [Related]
31. Effects of omeprazole on gastric mucosal blood flow in the conscious rat. Mattsson H; Larsson H Scand J Gastroenterol; 1987 May; 22(4):491-8. PubMed ID: 3602930 [TBL] [Abstract][Full Text] [Related]
33. Low gut microbiota diversity and dietary magnesium intake are associated with the development of PPI-induced hypomagnesemia. Gommers LMM; Ederveen THA; van der Wijst J; Overmars-Bos C; Kortman GAM; Boekhorst J; Bindels RJM; de Baaij JHF; Hoenderop JGJ FASEB J; 2019 Oct; 33(10):11235-11246. PubMed ID: 31299175 [TBL] [Abstract][Full Text] [Related]
34. Antisecretory and antiulcer effect of T-330, a novel reversible proton pump inhibitor, in rats. Kinoshita M; Saito N; Tamaki H Eur J Pharmacol; 1997 Mar; 321(3):325-32. PubMed ID: 9085044 [TBL] [Abstract][Full Text] [Related]
35. [Effect of long-term administration of antisecretary drugs on rat gastric histamine synthesis and acid secretion--compare with omeprazole and cimetidine]. Morita R; Harasawa S; Miwa T; Matsumoto M Nihon Shokakibyo Gakkai Zasshi; 1992 Oct; 89(10):2551-8. PubMed ID: 1404968 [TBL] [Abstract][Full Text] [Related]
36. Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication. Semb S; Helgstrand F; Hjørne F; Bytzer P World J Gastroenterol; 2017 Oct; 23(37):6907-6910. PubMed ID: 29085234 [TBL] [Abstract][Full Text] [Related]